NCT04135560 - A Study To Determine The Safety, Tolerability, Skin Irritation Potential, And PK Following Topical Application Of PF-07038124 In Healthy Participants | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 29, 2019

Primary Completion Date

April 10, 2020

Study Completion Date

April 10, 2020

Conditions

Dermatitis Atopic

Interventions

DRUG

PF-07038124 and Vehicle

PF-07038124 0.06% and vehicle Ointment BID applied to 1% Body Surface Area (BSA)

DRUG

PF-07038124 or vehicle

PF-07038124 0.01% or vehicle Ointment QD applied to 10% BSA

DRUG

PF-07038124 or vehicle

PF-07038124 0.01% or vehicle Ointment BID applied to 10% BSA

DRUG

PF-07038124 or vehicle

PF-07038124 0.03% or vehicle Ointment BID applied to 10% BSA

DRUG

PF-07038124 or vehicle

PF-07038124 0.06% or vehicle ointment BID applied to 10% BSA

DRUG

PF-07038124 or vehicle

PF-07038124 safe concentration or vehicle ointment BID applied to 20% BSA

DRUG

PF-07038124 or vehicle

PF-07038124 safe concentration or vehicle BID applied to 10% BSA

Trial Locations (1)

Pfizer New Haven Clinical Research Unit, New Haven